Pursuant to Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015 we are submitting herewith the disclosures received to the Company under Regulation 7(2)(b) of ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Chemkart India Limited has submitted a regulatory disclosure to BSE regarding the acquisition of equity shares by one of its Promoter-Directors, Mr. Ankit Shailesh Mehta (DIN: 06792217). Mr. Mehta purchased 10,200 equity shares of the company on the open market through BSE on March 20, 2026, at a total value of approximately Rs. 10.57 lakhs (around Rs. 103.6 per share). Following this purchase, his shareholding in the company increased from 44,34,865 shares (36.65%) to 44,45,065 shares (36.74%). The disclosure was filed by the company on March 23, 2026, in compliance with insider trading regulations.
This is a positive signal for retail investors as a Promoter-Director has increased his stake in the company through an open-market purchase, indicating insider confidence. However, the increase in shareholding is marginal (just 0.09 percentage points), so it is unlikely to move the stock price significantly on its own.